Human Genome Epidemiology Literature Finder
Records 1 - 30 (of 10028 Records) |
Query Trace: Breast Cancer[original query] |
---|
The association of FSCN1 (rs852479, rs1640233) and HOTAIR (rs920778) polymorphisms with the risk of breast cancer in Egyptian women. Molecular biology reports 2024 4 51 (1): 495. Eman Reda Galal, Dina A Abdelhakam, Lamiaa Khalaf Ahmed, Yasmine Elhusseny, Sherif El Prince Sayed, Noha H Eltawe |
Carrying SNP rs17506395 (T > G) in TP63 gene and CCR5?32 mutation associated with the occurrence of breast cancer in Burkina Faso. Open life sciences 2024 4 19 (1): 20220847. Lassina Traoré, Mousso Savadogo, Abdou Azaque Zouré, Touwendpoulimdé Isabelle Kiendrebeogo, Fabienne Marie B T B Soudre, Soayebo Dabre, Aida Djé Djénéba Traore, Marc Donald Wilfried Adico, Tilate Lare, Teega-Wendé Clarisse Ouedraogo, Rogomenoma Alice Ouedraogo, Abdoul Karim Ouattara, Edwige T Yelemkoure, Alexis Yobi Sawadogo, Nayi Zongo, Hierrhum Aboubacar Bambara, Christelle W Nadembega, Florencia W Djigma, Jacques Simpo |
Blood and Tissue Levels of Persistent Organic Pollutants and Genetic Susceptibility in Patients with Breast Cancer. Environmental toxicology and pharmacology 2024 4 104433. ?lgen Onat, Rasih Kocagöz, Merve Demirbügen Öz, Levent Yeniay, Yi?it Özer Tiftikçio?lu, Osman Zekio?lu, Gürdeniz Serin, Murat Özdemir, Ersin Gür, Halit Sinan Süzen, Hilmi Orh |
Population Pharmacokinetics of Sacituzumab Govitecan in Patients with Metastatic Triple-Negative Breast Cancer and Other Solid Tumors. Clinical pharmacokinetics 2024 4 . Abhishek G Sathe, Indrajeet Singh, Pratap Singh, Paul M Diderichsen, Xiaohui Wang, Peter Chang, Atiya Taqui, See Phan, Sandhya Girish, Ahmed A Othm |
The causal association between artificial sweeteners and the risk of cancer: a Mendelian randomization study. Food & function 2024 4 . Haotian Pan, Chenchen Feng, Ziting Zhou, Jiamin Huang, Jiasi Deng, Yuanyuan Zhou, Yuxuan Wang, Xinru Mu, Qian Wang, Ke Wang, Zhigang |
Case report: Emerging BRCA mutation confers benefit from olaparib after chemotherapy intolerance in advanced triple-negative breast cancer. Clinical case reports 2024 4 12 (4): e8680. Xia-Bo Shen, Jia-Yi Wu, Jia-Ying Li, Xi-Ying Shao, Xiao-Jia Wa |
CYP2C8 rs11572080 and CYP3A4 rs2740574 risk genotypes in paclitaxel-treated premenopausal breast cancer patients. Scientific reports 2024 4 14 (1): 7922. Hanaa R M Attia, Mahmoud M Kamel, Dina F Ayoub, Shereen H Abd El-Aziz, Mai M Abdel Wahed, Safa N Abd El-Fattah, Mahmoud A Ablel-Monem, Thanaa M Rabah, Amany Helal, Mona Hamed Ibrah |
BRCA1/2 mutation carriers vs the general breast cancer population (N?=?799,986): 21-gene assay-based molecular characterization. Breast cancer research and treatment 2024 4 . Rinat Yerushalmi, Adi Pomerantz, Ron Lewin, Shani Paluch-Shimon, Lior Soussan-Gutman, Frederick L Baehner, Hillary Voet, Avital Bareket-Samish, Inbal Kedar, Yael Goldberg, Tamar Peretz-Yablonski, Luna Kadou |
Population-based BRCA germline mutation screening in the Han Chinese identifies individuals at risk of BRCA mutation-related cancer: experience from a clinical diagnostic center from greater Shanghai area. BMC cancer 2024 4 24 (1): 411. Zhiyuan Wu, Qingyun Zhang, Yiting Jin, Xinju Zhang, Yanli Chen, Can Yang, Xuemei Tang, Haowen Jiang, Xiaoyi Wang, Xinli Zhou, Feng Yu, Bing Wang, Ming Gu |
A Cohort Study to Evaluate Genetic Predictors for Aromatase Inhibitor Musculoskeletal Symptoms (AIMSS): Results from ECOG-ACRIN E1Z11. Clinical cancer research : an official journal of the American Association for Cancer Research 2024 4 . Vered Stearns, Opeyemi A Jegede, Victor Tsu-Shih Chang, Todd C Skaar, Jeffrey L Berenberg, Ranveer Nand, Atif Shafqat, Nisha Lassi Jacobs, William Luginbuhl, Paul Gilman, Al B Benson, Judie R Goodman, Gary L Buchschacher, N Lynn Henry, Charles L Loprinzi, Patrick J Flynn, Edith P Mitchell, Michael Jordan Fisch, Joseph A Sparano, Lynne I Wagn |
Postpartum Breast Cancer and Survival in Women With Germline BRCA Pathogenic Variants. JAMA network open 2024 4 7 (4): e247421. Zhenzhen Zhang, Shangyuan Ye, Sarah M Bernhardt, Heidi D Nelson, Ellen M Velie, Virginia F Borges, Emma R Woodward, D Gareth R Evans, Pepper J Sched |
Preventing alpelisib-related hyperglycaemia in HR+/HER2-/PIK3CA-mutated advanced breast cancer using metformin (METALLICA): a multicentre, open-label, single-arm, phase 2 trial. EClinicalMedicine 2024 4 71 102520. Antonio Llombart-Cussac, José Manuel Pérez-Garcia, Manuel Ruiz Borrego, Pablo Tolosa, Salvador Blanch, Adela Fernández-Ortega, Ander Urruticoechea, Isabel Blancas, Cristina Saura, Beatriz Rojas, Begoña Bermejo, José Ponce Lorenzo, María Gion, Patricia Cortez-Castedo, Elisenda Llabres, Elena Galve, Juan Fernando Cueva, Ana López, José Luis Alonso-Romero, Santiago González-Santiago, Eduardo Martínez de Dueñas, Eva Ciruelos, Griselda Martrat, Petra Gener, Daniel Alcalá-López, Miguel Sampayo-Cordero, Fernando Gómez-Peralta, Javier Cort |
Mutational landscape of inflammatory breast cancer. Journal of translational medicine 2024 4 22 (1): 374. François Bertucci, Florence Lerebours, Michele Ceccarelli, Arnaud Guille, Najeeb Syed, Pascal Finetti, José Adélaïde, Steven Van Laere, Anthony Goncalves, Patrice Viens, Daniel Birnbaum, Emilie Mamessier, Céline Callens, Davide Bedognet |
Genomic Landscape of Circulating Tumor DNA in Patients With Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor-2-Negative Metastatic Breast Cancer Treated With Abemaciclib: Data From the SCRUM-Japan Cancer Genome Screening Project. JCO precision oncology 2024 4 8 e2300647. Masaya Hattori, Victoria Serelli-Lee, Yoichi Naito, Takashi Yamanaka, Hiroyuki Yasojima, Rikiya Nakamura, Takao Fujisawa, Mitsuho Imai, Yoshiaki Nakamura, Hideaki Bando, Tsutomu Kawaguchi, Takayuki Yoshino, Hiroji Iwa |
Association Between Polymorphisms in DNA Damage Repair Pathway Genes and Female Breast Cancer Risk. DNA and cell biology 2024 4 . Ying Wang, Yalan Sun, Mingjuan Tan, Xin Lin, Ping Tai, Xiaoqin Huang, Qing Jin, Dan Yuan, Tao Xu, Bangshun |
Real-world evaluation of deep learning algorithms to classify functional pathogenic germline variants. medRxiv : the preprint server for health sciences 2024 4 . Ryan D Chow, Ravi B Parikh, Katherine L Nathans |
Targeted genotyping for recurring variants in cancer susceptibility genes in non-Ashkenazi Jewish patients with breast cancer diagnosed ?50 years. Cancer 2024 4 . Rinat Bernstein-Molho, Narmeen Abu Shhada, Yael Laitman, Iris Netzer, Shelley Shoval, Eitan Friedm |
Efficacy of pembrolizumab and biomarker analysis in patients with WGS-based intermediate to high tumor mutational load: results from the Drug Rediscovery Protocol. Clinical cancer research : an official journal of the American Association for Cancer Research 2024 4 . Birgit S Geurts, Laurien J Zeverijn, Lindsay V M Leek, Jade M van Berge Henegouwen, Louisa R Hoes, Hanneke van der Wijngaart, Vincent van der Noort, Joris van de Haar, Annemiek van Ommen-Nijhof, Marleen Kok, Paul Roepman, Anne M L Jansen, Wendy W J de Leng, Maja J A de Jonge, Ann Hoeben, Carla M L van Herpen, Hans M Westgeest, Lodewyk F A Wessels, Henk M W Verheul, Hans Gelderblom, Emile E Voe |
Clinicopathological characteristics and eligibility for adjuvant olaparib of germline BRCA1/2 mutation carriers with HER2-negative early breast cancer. NPJ breast cancer 2024 4 10 (1): 28. Stefania Morganti, Qingchun Jin, Julie Vincuilla, Ryan Buehler, Sean Ryan, Samantha Stokes, Tonia Parker, Elizabeth A Mittendorf, Tari A King, Anna Weiss, Ann H Partridge, Brittany L Bychkovsky, Giuseppe Curigliano, Nabihah Tayob, Nancy U Lin, Judy E Garber, Sara M Tolaney, Filipa Lyn |
The impact of lipidome on breast cancer: a Mendelian randomization study. Lipids in health and disease 2024 4 23 (1): 109. Yuchen Cao, Meichen Ai, Chunjun L |
Incidental detection of ground glass nodules and primary lung cancer in patients with breast cancer: prevalence and long-term follow-up on chest computed tomography. Journal of thoracic disease 2024 4 16 (3): 1804-1814. Hye Sun Ryu, Han Na Lee, Jung Im Kim, Jung Kyu Ryu, Yu Jin L |
Expression of immune-related genes and breast cancer recurrence in women with ductal carcinoma in situ. European journal of cancer (Oxford, England : 1990) 2024 4 203 114063. Elena Guerini-Rocco, Federica Bellerba, Alberto Concardi, Sergio Vincenzo Taormina, Giulio Cammarata, Caterina Fumagalli, Aliana Guerrieri-Gonzaga, Debora Macis, Eliza Del Fiol Manna, Emanuela Balladore, Maria Cannone, Paolo Veronesi, Nicola Fusco, Bernardo Bonanni, Giuseppe Viale, Massimo Barberis, Sara Gandini, Matteo Lazzero |
Association between estrogen receptor alpha and aryl hydrocarbon receptor gene polymorphisms in the prognosis of breast cancer in Egypt. The Egyptian journal of immunology 2024 4 31 (2): 87-92. Sara A Aboelroos, Elsayed H M Eltamany, Faten A M Mohamed, Marwa A Sulim |
Racial/ethnic differences in 21-gene recurrence score and survival among patients with estrogen receptor-positive breast cancer. BMC cancer 2024 4 24 (1): 461. Jasmin Gill, Keerti Yendamuri, Udit Chatterjee, Song Yao, Oluwadamilola T Oladeru, Anurag K Singh, Sung Jun |
Safety of the Breast Cancer Adjuvant Radiotherapy in Ataxia-Telangiectasia Mutated Variant Carriers. Cancers 2024 4 16 (7): . Rayan Bensenane, Arnaud Beddok, Fabienne Lesueur, Alain Fourquet, Mathilde Warcoin, Marine Le Mentec, Eve Cavaciuti, Dorothée Le Gal, Séverine Eon-Marchais, Nadine Andrieu, Dominique Stoppa-Lyonnet, Youlia Kiro |
Association of preoperative and postoperative circulating tumour DNA (ctDNA) with PIK3CA gene mutation with risk of recurrence in patients with non-metastatic breast cancer. Surgical oncology 2024 4 54 102060. Fara Hassan, Jiang Huai Wang, Donal Peter O'Leary, Mark Corrigan, Henry Paul Redmo |
Phase II Study of Erdafitinib in Patients With Tumors With FGFR Amplifications: Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol K1. JCO precision oncology 2024 4 8 e2300406. Jun Gong, Alain C Mita, Zihan Wei, Heather H Cheng, Edith P Mitchell, John J Wright, S Percy Ivy, Victoria Wang, Robert C Gray, Lisa M McShane, Larry V Rubinstein, David R Patton, P Mickey Williams, Stanley R Hamilton, Ajjai S Alva, James V Tricoli, Barbara A Conley, Carlos L Arteaga, Lyndsay N Harris, Peter J O'Dwyer, Alice P Chen, Keith T Flaher |
Efficacy and safety of first-line treatment for metastatic triple-negative breast cancer: A network meta-analysis. Cancer pathogenesis and therapy 2024 4 2 (2): 81-90. Mingqiang Shi, Zhoujuan Li, Guoshuang Shen, Tianzhuo Wang, Jinming Li, Miaozhou Wang, Zhen Liu, Fuxing Zhao, Dengfeng Ren, Jiuda Zh |
Sacituzumab govitecan in metastatic triple-negative breast cancer patients treated at Institut Curie Hospitals: efficacy, safety, and impact of brain metastases. Breast cancer (Tokyo, Japan) 2024 4 . Alexandre De Moura, Delphine Loirat, Sarah Vaillant, Sinen Korbi, Nicolas Kiavue, Diana Bello Roufai, Laurence Escalup, Romain Desmaris, Pauline Vaflard, Paul Cottu, Jean-Yves Pierga, François-Clément Bidard, Luc Cabel, Alexandre Acram |
Identification and validation of Golgi apparatus-related signature for predicting prognosis and immunotherapy response in breast cancer. Journal of cancer research and clinical oncology 2024 2 150 (2): 61. Xin Chen, Pengting Tang, Ying Kong, Deqin Chen, Kejun Ta |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 22, 2024
- Content source: